Life after ESPRIT: Which first-line antiplatelet treatment should we use?

Philip B. Gorelick

doi:10.1111/j.1747-4949.2007.00086.x

Life after ESPRIT: Which first-line antiplatelet treatment should we use?

Philip B. Gorelick^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	40-42
Number of pages	3
Journal	International Journal of Stroke
Volume	2
Issue number	1
DOIs	https://doi.org/10.1111/j.1747-4949.2007.00086.x
State	Published - Feb 2007

ASJC Scopus subject areas

Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1747-4949.2007.00086.x

Cite this

@article{aa726dddb7254ff183fde6b37f0a766e,

title = "Life after ESPRIT: Which first-line antiplatelet treatment should we use?",

author = "Gorelick, {Philip B.}",

year = "2007",

month = feb,

doi = "10.1111/j.1747-4949.2007.00086.x",

language = "English (US)",

volume = "2",

pages = "40--42",

journal = "International Journal of Stroke",

issn = "1747-4930",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Life after ESPRIT

T2 - Which first-line antiplatelet treatment should we use?

AU - Gorelick, Philip B.

PY - 2007/2

Y1 - 2007/2

UR - http://www.scopus.com/inward/record.url?scp=33846690600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846690600&partnerID=8YFLogxK

U2 - 10.1111/j.1747-4949.2007.00086.x

DO - 10.1111/j.1747-4949.2007.00086.x

M3 - Article

C2 - 18705985

AN - SCOPUS:33846690600

SN - 1747-4930

VL - 2

SP - 40

EP - 42

JO - International Journal of Stroke

JF - International Journal of Stroke

IS - 1

ER -

Life after ESPRIT: Which first-line antiplatelet treatment should we use?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this